Edition:
United States

Jazz Pharmaceuticals PLC (JAZZ.OQ)

JAZZ.OQ on NASDAQ Stock Exchange Global Select Market

152.47USD
3 May 2016
Change (% chg)

-- (--)
Prev Close
$152.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
217,866
52-wk High
$194.73
52-wk Low
$108.50

JAZZ.OQ

Chart for JAZZ.OQ

About

Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $9,216.01
Shares Outstanding(Mil.): 60.44
Dividend: --
Yield (%): --

Financials

  JAZZ.OQ Industry Sector
P/E (TTM): 29.17 34.06 44.92
EPS (TTM): 5.23 -- --
ROI: 10.54 13.00 12.47
ROE: 22.19 13.69 13.34
Search Stocks

Jazz Pharmaceuticals' rare liver disorder drug wins U.S. approval

March 30 The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.

Mar 30 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : GlobalData
$300.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks